FNWA
PCVX icon

Financial Network Wealth Advisors’s Vaxcyte PCVX Stock Holding History

Financial Network Wealth Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15
Closed -$692 – 870
2025
Q4 		$692 Hold
15
– – ﹤0.01% 825
2025
Q3 		$540 Buy
+15
New +$497 ﹤0.01% 837
2025
Q2 		– Sell
-15
Closed -$566 – 840
2025
Q1 		$566 Buy
+15
New +$1.2K ﹤0.01% 770

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Financial Network Wealth Advisors's PCVX Position: Q1 2026 in Review

Financial Network Wealth Advisors sold out of Vaxcyte (PCVX) in Q1 2026, closing a stake of 15 shares — an estimated $692 sold.

Financial Network Wealth Advisors first reported a position in PCVX in Q1 2025 and held it in 3 quarters. The position peaked at $692 in Q4 2025. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Financial Network Wealth Advisors reported no remaining Vaxcyte position as of Q1 2026 after selling out during the quarter.
  • Financial Network Wealth Advisors sold 15 Vaxcyte shares in Q1 2026, an estimated $692.
  • Financial Network Wealth Advisors first reported a position in Vaxcyte in Q1 2025 and held it in 3 quarters.
  • Financial Network Wealth Advisors's Vaxcyte position peaked at $692 in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.